<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antibiotic regimens for pyogenic liver abscess</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antibiotic regimens for pyogenic liver abscess</h1>
<div class="graphic"><div class="figure"><div class="ttl">Antibiotic regimens for pyogenic liver abscess</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Regimen</td> <td class="subtitle1">Dose (adult)*</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Preferred<sup>¶</sup></td> </tr> <tr> <td class="subtitle3_left" colspan="2">Beta-lactam/beta-lactamase inhibitor:<sup>Δ</sup></td> </tr> <tr> <td class="indent2">Piperacillin-tazobactam</td> <td>3.375 or 4.5 g IV every six hours<sup>◊</sup></td> </tr> <tr> <td class="indent2">Ticarcillin-clavulanate<sup>§</sup></td> <td>3.1 g IV every four hours</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Third generation cephalosporin<sup>¥</sup> PLUS metronidazole:</td> </tr> <tr> <td class="indent2">Ceftriaxone <strong>plus</strong></td> <td>2 g IV once daily</td> </tr> <tr> <td class="indent2">Metronidazole</td> <td>500 mg IV or orally every eight hours</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Ampicillin PLUS gentamicin PLUS metronidazole:</td> </tr> <tr> <td class="indent2">Ampicillin <strong>plus</strong></td> <td>2 g IV every four to six hours</td> </tr> <tr> <td class="indent2">Gentamicin <strong>plus</strong></td> <td>5 to 7 mg per kg IV daily<sup>‡</sup></td> </tr> <tr> <td class="indent2">Metronidazole</td> <td>500 mg IV or orally every eight hours</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Alternative regimens<sup>¶</sup></td> </tr> <tr> <td class="subtitle3_left" colspan="2">Fluoroquinolone PLUS metronidazole:</td> </tr> <tr> <td class="indent2">Ciprofloxacin <strong>or</strong></td> <td>400 mg IV every 12 hours or 750 mg orally twice daily</td> </tr> <tr> <td class="indent2">Levofloxacin <strong>plus</strong></td> <td>500 or 750 mg IV or orally once daily</td> </tr> <tr> <td class="indent2">Metronidazole</td> <td>500 mg IV or orally every eight hours</td> </tr> <tr> <td class="subtitle3_left" colspan="2">Carbapenem:<sup>¶</sup><sup>†</sup></td> </tr> <tr> <td class="indent2">Imipenem-cilastatin</td> <td>500 mg IV every six hours</td> </tr> <tr> <td class="indent2">Meropenem</td> <td>1 g IV every eight hours</td> </tr> <tr> <td class="indent2">Ertapenem</td> <td>1 g IV once daily</td> </tr> </tbody></table></div><div class="graphic_lgnd">An empiric antibiotic regimen for pyogenic liver abscess should cover streptococci, enteric gram-negative bacilli, and anaerobes.</div><div class="graphic_footnotes"><p>IV: intravenous.</p>
<p>* Antibiotic doses should be adjusted appropriately for patients with renal insufficiency or other dose-related considerations.</p>
<p>¶ If the patient is in septic shock or if <em>Staphylococcus aureus</em> is a concern (eg, in a patient with an indwelling catheter or prior injection drug use), we typically add vancomycin. Refer to other UpToDate content for vancomycin dosing.</p>
<p>Δ These regimens have anaerobic activity without the addition of metronidazole. Unless involvement of <em>Entamoeba histolytica</em> is unlikely (eg, in patients with obvious biliary disease predisposing to pyogenic abscess), metronidazole 500 mg IV or orally every eight hours should be added until the causative organism has been identified or amebic serology or antigen testing has come back negative.</p>
<p>◊ The dose of 4.5 g every six hours should be used when <em>Pseudomonas</em> coverage is desired.</p>
<p>§ Ticarcillin-clavulanate is not available in the United States or Canada and is of limited availability in other locations.</p>
<p>¥ Cefepime is an additional cephalosporin choice and has expected activity against <em>Pseudomonas</em> when used at a dose of 2 g IV every eight hours.</p>
<p>‡ We do not continue a gentamicin-containing regimen for pyogenic liver abscess beyond 48 to 72 hours. If microbiologic data are unrevealing and a gentamicin-containing regimen was used for empiric therapy, we switch to one of these other empiric regimens to complete the antibiotic course. Refer to other UpToDate content about details on dosing for parenteral aminoglycosides.</p>
† Carbapenems are typically reserved for patients who should not use other options because of drug allergies or concern for resistant infection. Ertapenem lacks activity against <em>Acinetobacter</em> and <em>Pseudomonas</em> and, of the carbapenems, is not an appropriate choice for severe or nosocomial infection.</div><div id="graphicVersion">Graphic 117437 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
